TREM2 and cancer: Within our data, we found expression of SEMA6D (semaphorin 6D) by cancer cells, a ligand of TREM2 involved in axon guidance,55 suggesting that cancer cells may serve as a source of instigating ligands in this signaling pathway (Figure 4H).